ClearPoint Neuro, Inc. Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31)
ClearPoint Neuro, Inc. (CLPT) reported Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) of $4.95 million for the 1-month period ending 2012-02-29, per its 10-K filed 2014-03-28.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValueIssuedForCash · last filed 2014-03-28
- 2012-02-29: Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 1 month $4.95M.
| Period end | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) 1 month |
|---|---|
| 2012-02-29 | $4.95M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |